<DOC>
	<DOCNO>NCT02707952</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety ABT-493/ABT-530 Japanese adult chronic hepatitis C virus infection .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety ABT-493/ABT-530 Japanese Adults With Chronic Hepatitis C Virus Infection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>Screening central laboratory result indicate HCV single genotype infection appropriate treatment arm , without coinfection genotype . Chronic HCV infection define one following : Positive antiHCV antibody ( Ab ) and/or HCV RNA least 6 month Screening . A liver biopsy consistent chronic HCV infection . Must voluntarily sign date inform consent form , approve Institutional Review Board ( IRB ) /Independent Ethics Committee ( IEC ) prior initiation screen study specific procedure . Subjects must able understand adhere study visit schedule protocol requirement . Absence hepatocellular carcinoma ( HCC ) indicate ultrasound , compute tomography ( CT ) scan magnetic resonance imaging ( MRI ) . Female pregnant , plan become pregnant study , breastfeed ; male whose partner pregnant planning become pregnant study . Recent ( within 6 month prior study drug administration ) history drug alcohol abuse could preclude adherence protocol opinion investigator . Positive test result Screening hepatitis B surface antigen ( HBsAg ) anti human immunodeficiency virus antibody ( HIV Ab ) . Receipt investigational product within time period equal 10 halfâ€‘lives product , know , minimum 6 week ( whichever longer ) prior study drug administration . Consideration investigator , reason , subject unsuitable candidate receive ABT493/ABT530 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Compensated cirrhosis</keyword>
	<keyword>Hepatitis C Genotype 1</keyword>
	<keyword>Hepatitis C Genotype 5</keyword>
	<keyword>Non-cirrhotic</keyword>
	<keyword>Hepatitis C virus</keyword>
	<keyword>Hepatitis C Genotype 6</keyword>
	<keyword>Hepatitis C Genotype 3</keyword>
	<keyword>Hepatitis C Genotype 4</keyword>
	<keyword>Renal impairment</keyword>
	<keyword>Hepatitis C Genotype 2</keyword>
	<keyword>Chronic Hepatitis C</keyword>
</DOC>